http://www.pharmaasia.comPharmaAsia - Drug Developmenten-USCopyright 2012 Ten Alps Communications Asia. All rights reserved.Thu, 9 Feb 2012 19:20:16 +0800http://www.pharmaasia.com/article/life-technologies-appoints-president-of-medical-sciences/9325Life Technologies announced that Ronnie Andrews, former CEO of Clarient and Segment Leader, GE Molecular Diagnostics, has joined the company as president, medical sciences.http://www.pharmaasia.com/article/life-technologies-appoints-president-of-medical-sciences/9325Fri, 10 Feb 2012 00:00:00 +0800http://www.pharmaasia.com/article/pbl-interferonsource-collaborates-with-avanza/9300PBL InterferonSource (PBL) and AVANZA Laboratories announced collaboration between their two organizations that will focus on enhancing their ability to service the biopharmaceutical industry.http://www.pharmaasia.com/article/pbl-interferonsource-collaborates-with-avanza/9300Fri, 13 Jan 2012 00:00:00 +0800http://www.pharmaasia.com/article/icon-acquires-beijingwits-medical-consulting/9299ICON has agreed, subject to closing conditions, to acquire BeijingWits Medical Consulting, a leading CRO in China. The transaction is expected to close in the first quarter of 2012.http://www.pharmaasia.com/article/icon-acquires-beijingwits-medical-consulting/9299Wed, 11 Jan 2012 00:00:00 +0800http://www.pharmaasia.com/article/icon-medical-imaging-is-rated-as-top-provider-in-imaging-industry-survey/9294ICON announced that its medical imaging division was rated as the top provider of imaging services according to an industry survey conducted by Blue Pyramid Consulting, an affiliate of the Avoca Group.http://www.pharmaasia.com/article/icon-medical-imaging-is-rated-as-top-provider-in-imaging-industry-survey/9294Thu, 5 Jan 2012 00:00:00 +0800http://www.pharmaasia.com/article/icon-development-solutions-appoints-general-manager-of-asia-pacific/9291ICON announced that its development solutions division has appointed Dr Daniel Tang as general manager, Asia Pacific. Dr Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with key opinion leaders for early phase clinical testing.http://www.pharmaasia.com/article/icon-development-solutions-appoints-general-manager-of-asia-pacific/9291Mon, 12 Dec 2011 00:00:00 +0800http://www.pharmaasia.com/article/bio-images-and-medimetrics-partner-to-deliver-the-next-generation-of-smart-pill-technology/9261IntelliCap set to speed up clinical research as part of innovative drug delivery package.http://www.pharmaasia.com/article/bio-images-and-medimetrics-partner-to-deliver-the-next-generation-of-smart-pill-technology/9261Tue, 25 Oct 2011 00:00:00 +0800http://www.pharmaasia.com/article/agilent-technologies-and-university-of-technology-sydney-open-joint-nuclear-magnet-resonance-facility/9256NMR facility will be home to cutting-edge technology to support a range of UTS staff and student research projects.http://www.pharmaasia.com/article/agilent-technologies-and-university-of-technology-sydney-open-joint-nuclear-magnet-resonance-facility/9256Thu, 20 Oct 2011 00:00:00 +0800http://www.pharmaasia.com/article/nuvilex-s-affiliate-presents-cell-in-a-box-technology-in-seoul/9247BIO KOREA 2011 attracted over 4,500 attendees.http://www.pharmaasia.com/article/nuvilex-s-affiliate-presents-cell-in-a-box-technology-in-seoul/9247Fri, 14 Oct 2011 00:00:00 +0800http://www.pharmaasia.com/article/launch-of-biolynx-provides-a-boost-for-the-international-malaria-research-community/9241New NUS spin-off company launches at TechVenture 2011.http://www.pharmaasia.com/article/launch-of-biolynx-provides-a-boost-for-the-international-malaria-research-community/9241Wed, 12 Oct 2011 00:00:00 +0800http://www.pharmaasia.com/article/bi-axial-bioreactor-set-to-revolutionise-pre-clinical-trials-in-the-field-of-regenerative-medicine/9238Technology jointly developed by National University of Singapore and Singapore Polytechnic, and commercialised by local start-up company.http://www.pharmaasia.com/article/bi-axial-bioreactor-set-to-revolutionise-pre-clinical-trials-in-the-field-of-regenerative-medicine/9238Mon, 10 Oct 2011 00:00:00 +0800